Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.05
+0.46 (6.98%)
At close: Mar 9, 2026, 4:00 PM EDT
6.88
-0.17 (-2.41%)
After-hours: Mar 9, 2026, 7:14 PM EDT
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $151.51 million as of March 9, 2026. Its market cap has increased by 139.34% in one year.
Market Cap
151.51M
Enterprise Value
106.72M
1-Year Change
139.34%
Ranking
Category
Stock Price
$7.05
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $151.51M, an increase of 127.88%. That is a compound annual growth rate of 19.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 141.63M | 14.21% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fate Therapeutics | 154.63M |
| Innate Pharma | 151.10M |
| Zentalis Pharmaceuticals | 148.60M |
| Corbus Pharmaceuticals Holdings | 148.41M |
| MacroGenics | 141.07M |
| Artiva Biotherapeutics | 140.89M |
| Sangamo Therapeutics | 140.31M |
| Connect Biopharma Holdings | 138.64M |